Financials

  • Market Capitalization 4.1993 B
  • Employee 100
  • Founded 2019
  • CEO N/A
  • Website www.newamsterdampharma.com
  • Headquarter Netherlands
  • FIGI N/A
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-20.4
Price to sales ratio
184.61
Dividends per share
Dividend yield %

Noticias